Skip to main content

Methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Brand names: AlleRx Dose Pack (AM Dose), Allerx-D, Amdry-D, Extendryl PSE, Respivent-D, Sudatrate

Methscopolamine / pseudoephedrine Pregnancy Warnings

Methscopolamine-pseudoephedrine has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Methscopolamine-pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Methscopolamine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of methscopolamine-pseudoephedrine into human milk. The manufacturer recommends that a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Methscopolamine/pseudoephedrine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. (2002) "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)

References for breastfeeding information

  1. (2002) "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.